Source comparison
Summary: Epitalon versus Thymosin Alpha-1 for longevity research
Epitalon and Thymosin Alpha-1 target mechanistically distinct ageing hallmarks — telomere attrition (Epitalon: TERT +1.4–1.6×, telomere +0.4–0.6kb, pineal melatonin restoration) versus immune senescence (Tα1: sjTREC +28–36%, Foxp3+ Treg +34–42%, NK cytotoxicit
This comparison does not assign a generated winner or score.
- Epitalon and Thymosin Alpha-1 target mechanistically distinct ageing hallmarks — telomere attrition (Epitalon: TERT +1.4–1.6×, telomere +0.4–0.6kb, pineal melatonin restoration) versus immune senescence (Tα1: sjTREC +28–36%, Foxp3+ Treg +34–42%, NK cytotoxicity +38–44%). At the systems level they are potentially additive, with Epitalon operating upstream in haematopoietic progenitor supply and Tα1 operating midstream in thymic T-cell generation efficiency. A research programme addressing both mechanisms in parallel provides superior mechanistic coverage of the ageing biology landscape than either compound studied alone, and combination arms with staged mechanistic endpoint sampling are the appropriate experimental design for characterising their interaction.
- William is a research analyst at Peptides Lab UK, specialising in research peptides, laboratory compounds, and sourcing standards for high-purity peptide products.